LEVATED intracranial pressure (ICP) or inadequate cerebral perfusion pressure (CPP) and cerebral blood flow (CBF) are common causes of secondary brain damage in head-injured patients. In patients with raised ICP, it is a common practice to position the patient in bed with the head elevated above the level of the heart. Kenning, et a[., 4 reported that elevating the head to 45* or 90* significantly reduced ICP. However, some studies suggest that head elevation may also lower the CPP. Durward, et al.,2 studied the effect of head elevation at 0 ~ (horizontal), 15", 30*, or 60 ~ on ICP, systemic and pulmonary pressure, and CPP in patients with intracranial hypertension. They concluded that 15" or 30* of head elevation significantly reduced ICP while maintaining CPP and cardiac output. However, further elevation of the head to 60* caused an increase in ICP and a significant decrease in CPP and cardiac output. More recently, Rosner, et a/., [16] [17] [18] [19] have emphasized the importance of adequate CPP and have provided physiological and clinical evidence suggesting that CPP is maximum when patients are in the horizontal position, even though ICP is usually higher in this position. Davenport, etal .,' assessed the role of head elevation at 20", 40", or 60 ~ in eight patients suffering from hepatic coma. They found inconsistent effects of head elevation on ICP but a significant decrease in mean arterial blood pressure (MABP) and CPP at 40* and 60*. No study has yet measured CBF when evaluating the effects of postural changes on cerebral perfusion. As maintenance of adequate CBF is the primary rationale for maintaining adequate CPP in patients with increased ICP, we have studied the changes in CBF, as well as changes in ICP, CPP, and other cerebral and systemic physiological parameters induced by changes in head position in patients with head injury.
Clinical Material and Methods
Twenty-two head-injured patients admitted to the neurosurgical intensive care unit at Ben Taub General Hospital between January, 1990, and January, 1991, were studied. The demographic characteristics of the patients are given in Table 1 . The mean age of the patients was 35 years (range 18 to 75 years). The primary diagnosis was subdural hematoma in eight patients, cerebral contusion in five, intracerebral hematoma in two, epidural hematoma in two, diffuse axonal injury in two, gunshot wound to the head in two, and traumatic subarachnoid hemorrhage in one. Postresuscitation Glasgow Coma Scale scores were 3 to 5 in three patients, 6 to 8 in 14, and 9 to 12 in five. At 3 months after injury, six patients bad a good recovery, seven were moderately disabled, five were severely disabled, one was in a permanent vegetative state, and three had died (Table 1) .
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All patients were treated according to a protocol that emphasized early intubation and respiratory support, prompt evacuation of intracranial hematomas, and prevention of secondary insults to the brain. 13 The patients were initially ventilated to maintain a PaO2 of 100 mm Hg or above and a PaCO2 of 30 to 35 mm Hg. Intracranial pressure greater than 20 mm Hg was treated by cerebrospinal fluid (CSF) drainage, hyperventilation (PaCO2 25 to 30 mm Hg), sedation, paralysis, and administration of mannitol. Barbiturate coma was induced only if ICP was refractory to the above treatment. 3 Medications included morphine for sedation, pancuronium for paralysis, and phenytoin for seizure prophylaxis. The treatment protocols were approved by the Institutional Review Board of Baylor College of Medicine, and informed consent for each patient was obtained from the next of kin.
Within 72 hours after injury, two consecutive sets of physiological measurements were performed. In the first 13 patients, the initial set of measurements was performed with the head elevated to 300; in the subsequent nine patients, the initial set was taken at 0* head elevation. The patient's head elevation was changed after the initial set of measurements and a second set of measurements was taken 45 minutes later. Measurements were made of CBF (using the Kety-Schmidt N20 techniqueS-7), ICP (measured with the transducer zeroed at the level of the foramen of Monro), arteriovenous oxygen difference, cerebral metabolic rate of oxygen (CMRO2), oxygen saturation in the jugular bulb, cerebrovascular resistance (CVR), PaCO2, PaO2, arteriovenous difference of lactate, and MABP. The MABP was measured with the transducer zeroed at the level of the foramen of Monro, giving an estimate of the mean carotid pressure (MCP), which was then used for calculation of the CPP.
Differences were computed by subtracting the value obtained when the patient was lying flat from the value obtained when the head was elevated to 30 ~ . These differences were evaluated using the paired t-test. Comparisons among subgroups of patients were made using analysis of variance of the individual differences. At 30", the intracranial pressure (ICP) was lower in 77% of patients, higher in 14%, and the same in 9%; mean carotid pressure (MCP) was lower in 59%, higher in 23%, and the same in 18%; cerebral perfusion pressure (CPP) was lower in 55% and higher in 45%; and cerebral blood flow (CBF) was lower in 36%, higher in 36%, and the same in 14%. See text for analysis of the significance of the differences.
Results
The effects of head elevation on ICP, MCP, CPP, and CBF are illustrated in Fig. 1 and are given in Table  2 The mean values for CPP and CBF were unaffected by head elevation: 70.2 ___ 18.1 mm Hg at 30 ~ and 69.7 + 18.7 mm Hg at 0 ~ for CPP, and 47.8 _+ 16.9 ml/100 gm/min at 30* and 48.9 _+ 20.4 ml/100 gm/min at 0 ~ for CBF. None of the other parameters showed a statistically significant difference between head elevations at 30* and at 0 ~ The results were not affected by whether the head was at 30* or at 0* for the initial measurements.
Correlation analysis revealed a significant relationship between the ICP level at 0* head elevation and the amount of change in ICP after 30* head elevation (r = -0.5890). The higher the ICP with the patient in the horizontal position (0*), the greater the reduction in ICP at head elevation of 30* (Fig. 2) . The effect of head Although CBF was unchanged with head elevation to 30 ~ when the data for all 22 patients were averaged, in five patients the CBF fell by more than 5 ml/100 gm/min with head elevation. In these five, CBF fell from a mean of 67.2 + 26 ml/100 gm/min at 0 ~ to 50.7 _+ 16.5 ml/100 gin/rain at 30 ~ (p < 0.05). Therefore, we tried to identify physiological parameters that would predict such a fall. The CMRO2 was also lower after head elevation in these five patients, falling from 1.09 + 0.5 #mol/100 gm/min at 0* to 0.9 _ 0.5 ~mol/100 gm/min at 30*. As in the entire group, MCP and ICP were lower with the head elevated: 83.2 _ 13.2 mm Hg versus 90.8 _ 11.9 mm Hg for MCP, and 18 +_ 3.7 mm Hg versus 22.4 _+ 7 mm Hg for ICP. The CVR was higher at 30* elevation than at 0": 1.51 _+ 0.56 versus 1.22 _+ 0.49, respectively. Comparison of the changes in these five patients to those occurring in the other 17 patients revealed that the changes in CBF, CMRO2, and CVR were significant (p = 0.0001 for CBF, p = 0.01 for CMRO2, and p = 0.0221 for CVR). Although the decrease in CPP in these five patients was not significantly different from that observed in the other patients (p = 0.119), the combination of increased CVR and decreased CPP resulted in a decrease in CBF. Further analysis revealed that in four of these patients, the CBF, although lower at 30 ~ head elevation, was still within the normal range (> 35 ml/100 gm/min). In only one of the five patients did the CBF drop below 35 ml/100 gin/rain (from 37 to 25 ml/100 gin/rain). In this patient, the CPP was low: 59 mm Hg at 0 ~ and 50 mm Hg at 30 ~ Interestingly, the ICP rose marginally in this patient from 12 mm Hg at 0 ~ head elevation to 14 mm Hg at 30 ~ Other than the suggestion that a low CPP may be associated with a fall in CBF with head elevation, the five patients in whom head elevation produced a decrease in CBF of more than 5 ml/100 gm/min had no distinguishing features.
Discussion
The ideal head position for patients with head injury has been disputed in recent years. Rosner 16 provided evidence that plateau waves are triggered by a fall in CPP and that maintaining CPP above 70 to 80 mm Hg prevented plateau waves. In patients with intracranial hypertension, Rosner and coworkers ls'19 advocated keeping the patient's head at 0 ~ elevation and using fluid expansion or pharmacological means to maintain CPP. Our data indicate that, although the MCP is lower at 30 ~ head elevation than at 0", CPP and CBF are not significantly altered in most patients by head elevation to 30*.
Because the MCP could not be obtained by direct measurement of the internal carotid artery pressure in the patients we studied, we used the MABP recorded with the transducer placed at the level of the foramen of Monro as an estimate of the MCP, a technique commonly used to compute CPP? 8 However, the results of a study by Woischneck, et al., 22 suggest that the fall in MCP that we observed at 30* head elevation may be largely an artifact of this measurement technique. In their study addressing the accuracy of CPP measurements, they found the pressure in the superficial temporal artery to be almost identical to the pressure in the internal carotid artery. When evaluating the effect of head elevation on CPP, computed using the pressure of the superficial temporal artery, they found the CPP to be constant when the head was elevated from 0* to 30*. If our measurement technique implied a fall in MCP that did not actually occur, it would suggest that the CPP might actually increase at 30 ~ of head elevation and explain the lack of change in CBF seen in our patients with head elevation.
We have also demonstrated a direct relationship between the ICP level and the change in ICP after head elevation. Our data suggest that in head-injured patients with normal ICP, head position does not greatly affect ICP and that these patients can be positioned either horizontally or with the head elevated to 30 ~ . However, when the ICP is increased, elevation of the head is very effective in reducing the ICP. This is apparently due to: 1) hydrostatic displacement of the CSF from the cranial cavity to the spinal subarachnoid space; 4 and 2) facilitated venous outflow from the brain.S-10'14'ls'2 L The contributions of CSF displacement and changes in venous volume to the reduction in ICP in head-injured patients after head elevation may depend upon the relative size of each intracranial compartment at the time of head elevation, m.~v In patients with raised ICP, the intracranial compliance decreases, t~ 12,20 and smaller changes in intracranial volume, such as those produced by CSF displacement, will produce greater changes in ICP.
Although the overall results of the present study show no effect of head elevation on CBF, one must bear in mind that our measurements are of global CBF and that regional areas of decreased CBF may exist in the presence of normal global blood flow measurements. Only in one patient did the CBF fall to ischemic levels after head elevation, and the vasodilatory cascade suggested by Rosner t<~7 seemed to be demonstrable. In this patient, the low CPP (59 mm Hg) emphasizes once more the importance of maintaining adequate levels of CPP. The results of the present study suggest that, in general, head-injured patients with raised ICP should be maintained with the head elevated to 30 ~ which will produce a fall in ICP without a significant decrease in CBF in the majority of these patients.
